HIF-1α overexpression has been identified in a number of tumor types, including pancreatic, head and neck, breast, renal, ovarian, bladder, brain, colorectal, and prostate cancers, and overexpression correlates with increased angiogenesis and metastasis [15, 16]. Here, HIF1A is linked to neoplasm.